Cas:159532-59-9 (S)-1-Boc-piperazine-2-carboxylic acid manufacturer & supplier

Chemical Name:(S)-1-Boc-piperazine-2-carboxylic acid

CAS.NO:159532-59-9

Synonyms:1,2-Piperazinedicarboxylic acid, 1-(1,1-dimethylethyl) ester, (2S)-;S-4-Boc-Piperazine-3-carboxylicacid;(2S)-1-{[(2-Methyl-2-propanyl)oxy]carbonyl}-2-piperazinecarboxylic acid;(S)-Piperazine-1,2-dicarboxylic acid 1-tert-butyl ester;(2S)-1-[(tert-butoxy)carbonyl]piperazine-2-carboxylic acid;REF DUPL: (S)-1-N-Boc-piperazine-2-carboxylic acid;(2S)-1-{[(1,1-dimethylethyl)oxy]carbonyl}-2-piperazinecarboxylic acid;1-Boc-Piperazine-2-carboxylic acid;(2S)-1-(tert-Butoxycarbonyl)piperazine-2-carboxylic acid;(S)-1-(tert-butyloxycarbonyl)piperazine-2-carboxylic acid

Molecular Formula:C₁₀H₁₈N₂O₄

Molecular Weight:230.261

HS Code:

Physical and Chemical Properties:

Melting point:243-247ºC (dec.)

Boiling point:371.8±37.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.495

PSA:78.87000

Exact Mass:230.126663

LogP:0.26

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,2-Piperazinedicarboxylic acid, 1-(1,1-dimethylethyl) ester, (2S)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(S)-1-(tert-butyloxycarbonyl)piperazine-2-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2S)-1-{[(1,1-dimethylethyl)oxy]carbonyl}-2-piperazinecarboxylic acid Use and application,(S)-Piperazine-1,2-dicarboxylic acid 1-tert-butyl ester technical grade,usp/ep/jp grade.

Related News: The Wuhan coronavirus has brought back memories of the 2003 outbreak of the severe acute respiratory syndrome, known as SARS, which infected more than 8,000 people and killed 774. (S)-1-Boc-piperazine-2-carboxylic acid manufacturer Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday. (S)-1-Boc-piperazine-2-carboxylic acid supplier First up is Lilly, which reached all-time highs this week as attention turned to its once highly hyped donanemab, another anti-amyloid that saw a mixed bag of data back in March, with a slight win on one disease scale undermined by a failure on a more widely used measure of Alzheimer’s. (S)-1-Boc-piperazine-2-carboxylic acid vendor The agency said it was not yet ready to authorize Emergent BioSolutions Inc’s (EBS.N) plant for manufacturing the J&J vaccine. (S)-1-Boc-piperazine-2-carboxylic acid factory In a memo to Branchburg employees on May 20, Nellie Clark, head of the plant, summed up the outside lawyers’ findings: “In the end and very importantly, allegations that Lilly made false statements to the FDA were not substantiated.”